Source: News & Observer
Hundreds of highly paid GlaxoSmithKline scientists will find out today whether they still have jobs as the drug maker steps up a restructuring program it announced in October to counter slow sales.
A GSK spokeswoman acknowledged the job cuts but declined to provide details, except to say that employees will be notified this week and receive severance packages.
"There is a whole lot of reshuffling going on companywide," said Melinda Stubbee. "Unfortunately, as part of that process, jobs are going to be lost."
FULL STORY
Read the new book, The Evidence, However, Is Clear...The Seroxat Scandal
By Bob Fiddaman
ISBN: 978-1-84991-120-7
CHIPMUNKA PUBLISHING
AVAILABLE FOR DOWNLOAD HERE
PAPERBACK COMING SOON
No comments: